Quick Hits: Breast Implants and Lymphoma, Gut Bacteria and Antibiotic Resistance & More

Quick Hits: Transvaginal Mesh Pulled, New Weight Loss Drug & More

The FDA released an update regarding the association between breast implants and lymphoma. The agency is reporting that they are aware of 414 cases of BIA-ALCL, a rare T-cell lymphoma that can develop following breast implants. Also, studies estimate that the lifetime risk of developing BIA-ALCL for patients with textured breast implants ranges from 1 in 3,817 to 1 in 30,000. This new update does not sway the FDA’s recommendations regarding breast implants. The agency believes that getting breast implants is a “very personal decision” that should be made after carefully evaluating all of the risks and benefits. Published March 21, 2018. Via FDA.

One in 4 commonly used drugs can impact gut bacteria, leading to antibiotic resistance, according to new research from the European Molecular Biology Laboratory. Researchers screened over 1000 drugs currently available on the market and tested their impact on 40 strains of bacteria from the human gut. The results showed that 24% (250 out of 923) of non-antibiotic drugs affected the growth of at least one strain of bacteria in vitro. Published March 19, 2018. Via Nature.

A new daily oral contraceptive developed for men is safe and effective, a small study suggests. Researchers from the University of Washington shared the promising results of the small clinical trial that examined the experimental contraceptive known as dimethandrolone undecanoate, or DMAU. The new pill is said to lower testosterone levels and other hormones involved in sperm production. The research team examined 83 men between the ages of 18 and 50 who took DMAU daily for about a month. The results indicated that those taking the highest DMAU dosage had significantly lower testosterone levels along with two drastically suppressed hormones essential for sperm production. One caveat associated with the results is that the men only took the pill for a month. Published March 18, 2018. Via Endocrine Society.


Alanna McCatty

Alanna McCatty

Alanna McCatty is founder and CEO of McCatty Scholars, an organization that devises and implements financial literacy programs for students to combat the nationwide issue of the loss of educational opportunity due to the ramifications of burdensome student debt. At MedShadow, she reports on new findings and research on the side effects of prescription drugs. She is a graduate of Pace University.


Did you find this article helpful?


Latest News

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Synthetic Red Blood Cells, NOAC’s for Atrial Fibrillation, Surgery to Ease Sciatica Pain

Researchers have managed to create artificial red blood cells that can transport medication. Compared to the popular anticoagulant Warfarin, NOAC’s may be superior for treating atrial fibrillation patients with prior intracranial hemorrhage. Also, surgery may be the preferred choice for reducing leg pain in patients with sciatica.  Synthetic Red Blood…

FDA Recalls Metformin and NP Thyroid

FDA Recalls Metformin and NP Thyroid

The FDA has issued a recall of two drugs–NP Thyroid and Metformin–after testing revealed that they weren’t up to code. Read more below, and if you’re taking either medication, please be sure to contact your doctor for how to continue treatment responsibly.  NP Thyroid Recalled Thirteen lots of NP Thyroid,…

  • Advertisement